Development and Validation of a Prognostic Clinical Risk Score for Subsequent Atopic Dermatitis Risk

Clin Exp Allergy. 2024 Sep 24. doi: 10.1111/cea.14567. Online ahead of print.

Authors

Tamar Landau¹, Keren Gamrasni¹, Alex Levin¹, Yotam Barlev¹, Oliver Sanders², Shira Benor^{3

4

5}, Michael Brandwein^{1

6}

Affiliations

¹ MYOR Diagnostics Ltd., Zichron Yaakov, Israel.
² Department of Pediatrics, Hadassah University Medical Center, Jerusalem, Israel.
³ Allergy and Clinical Immunology Unit, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
⁴ Leumit Health Services, Tel Aviv, Israel.
⁵ Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
⁶ Department of Molecular Biology, Ariel University, Ariel, Israel.

PMID: 39318158
DOI: 10.1111/cea.14567

No abstract available

Grants and funding

MYOR Diagnostics